Evidence map›Paper›PMID 36950091›Full record

ArticleJHEP reports : innovation in hepatology2023

Transcriptomic landscapes of effective and failed liver regeneration in humans.

Patrick Starlinger, Laura Brunnthaler, Chantal McCabe, David Pereyra, Jonas Santol, Jessica Steadman, Matthias Hackl, Susanna Skalicky, Hubert Hackl, Raphael Gronauer and 8 more

Open access · goldAbstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Spatial genomics: mapping human steatotic liver disease.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 2 countries.

Patrick StarlingerDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Laura BrunnthalerCenter of Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria.
Chantal McCabeDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
David PereyraDepartment of Surgery, Medical University of Vienna, General Hospital, Vienna, Austria.
Jonas SantolDepartment of Surgery, HPB Center, Viennese Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.
Jessica SteadmanDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Matthias HacklTAmiRNA GmbH, Vienna, Austria.
Susanna SkalickyTAmiRNA GmbH, Vienna, Austria.
Hubert HacklInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Raphael GronauerInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Daniel O'BrienDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Renate KainClinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Petra HirsovaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Gregory J GoresDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Chen WangDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Thomas GruenbergerDepartment of Surgery, HPB Center, Viennese Health Network, Clinic Favoriten and Sigmund Freud Private University, Vienna, Austria.
Rory L SmootDepartment of Surgery, Division of Hepatobiliary and Pancreatic Surgery, Mayo Clinic, Rochester, MN, USA.
Alice AssingerCenter of Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria.
Mayo Clinic · USMayo Clinic in Florida · USMedical University of Vienna · ATInnsbruck Medical University · ATMayo Clinic in Arizona · USSigmund Freud Privatuniversität Wien · ATVienna General Hospital · AT

Funding

Pathobiology of Nonalcoholic SteatohepatitisR01DK130884 · NIDDK · MAYO CLINIC ROCHESTER · PI Petra Hirsova · 2021 to 2026
$2.5M
Novel coagulation-dependent mechanisms of liver regeneration to detect and prevent liver dysfunction after partial hepatectomyR01DK122813 · NIDDK · MICHIGAN STATE UNIVERSITY · PI LUYENDYK, JAMES P · 2020 to 2024
$2.0M
Austrian Science Fund FWF P 32064NIDDK NIH HHS R01 DK122813NIDDK NIH HHS R01 DK130884
6 · The paper itself

Abstract

Background & Aims: Although extensive experimental evidence on the process of liver regeneration exists, in humans, validation is largely missing. However, liver regeneration is critically affected by underlying liver disease. Within this project, we aimed to systematically assess early transcriptional changes during liver regeneration in humans and further assess how these processes differ in people with dysfunctional liver regeneration. Methods: Blood samples of 154 patients and intraoperative tissue samples of 46 patients undergoing liver resection were collected and classified with regard to dysfunctional postoperative liver regeneration. Of those, a matched cohort of 21 patients were used for RNA sequencing. Samples were assessed for circulating cytokines, gene expression dynamics, intrahepatic neutrophil accumulation, and spatial transcriptomics. Results: Individuals with dysfunctional liver regeneration demonstrated an aggravated transcriptional inflammatory response with higher intracellular adhesion molecule-1 induction. Increased induction of this critical leukocyte adhesion molecule was associated with increased intrahepatic neutrophil accumulation and activation upon induction of liver regeneration in individuals with dysfunctional liver regeneration. Comparing baseline gene expression profiles in individuals with and without dysfunctional liver regeneration, we found that dual-specificity phosphatase 4 (DUSP4) expression, a known critical regulator of intracellular adhesion molecule-1 expression in endothelial cells, was markedly reduced in patients with dysfunctional liver regeneration. Mimicking clinical risk factors for dysfunctional liver regeneration, we found liver sinusoidal endothelial cells of two liver disease models to have significantly reduced baseline levels of DUSP4. Conclusions: Exploring the landscape of early transcriptional changes of human liver regeneration, we observed that people with dysfunctional regeneration experience overwhelming intrahepatic inflammation. Subclinical liver disease might account for DUSP4 reduction in liver sinusoidal endothelial cells, which ultimately primes the liver for an aggravated inflammatory response. Impact and implications: Using a unique human biorepository, focused on liver regeneration (LR), we explored the landscape of circulating and tissue-level alterations associated with both functional and dysfunctional LR. In contrast to experimental animal models, people with dysfunctional LR demonstrated an aggravated transcriptional inflammatory response, higher intracellular adhesion molecule-1 (ICAM-1) induction, intrahepatic neutrophil accumulation and activation upon induction of LR. Although inflammatory responses appear rapidly after liver resection, people with dysfunctional LR have exaggerated inflammatory responses that appear to be related to decreased levels of LSEC DUSP4, challenging existing concepts of post-resectional LR.

Indexed as

ALT, alanine aminotransferaseAST, aspartate aminotransferaseCASH, chemotherapy associated steatohepatitisDLR, dysfunctional LRDUSP-4DUSP4, dual-specificity phosphatase 4FDR, false discovery rateFLR, functional LRFPKM, fragments per kilobase of transcript per million mapped readsHumanICAM-1, intracellular adhesion molecule-1InflammationIPA, Ingenuity Pathway AnalysisIVCL, inferior vena cava ligationLiver regenerationlogCPM, log counts per millionLPS, lipopolysaccharideLR, liver regenerationLSEC, liver sinusoidal endothelial cellMFI, mean fluorescence intensityMPO, myeloperoxidaseNASH, non-alcoholic steatohepatitisNeutrophilsPCA, principal component analysisPOD1, 1 day after liver resectionPOD5, 5 days after liver resectionpTPM, protein-coding transcripts per millionSTRING, Search Tool for the Retrieval of Interacting Genes/ProteinsTMM, trimmed mean of M valuesTNF, tumour necrosis factor

Identifiers

PMID36950091
PMCPMC10025111
OpenAlexW4318955087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.